| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.7M | +19.9% | +21.0% |
| Cost of Revenue | $26.8M | -4.4% | -9.1% |
| Gross Profit | -$8.1M | +35.0% | +42.4% |
| R&D Expense | $35.3M | -10.3% | -30.3% |
| SG&A Expense | $14.1M | +166.4% | -53.3% |
| Operating Income | -$74.7M | -89.1% | +35.6% |
| Pre-tax Income | -$85.9M | -277.5% | -411.6% |
| Income Tax | -$25K | -116.7% | -115.8% |
| Net Income | -$85.8M | -274.9% | -413.3% |
| EPS (Basic) | -$1.29 | -108.1% | -2250.0% |
| EPS (Diluted) | -$1.29 | -108.1% | -437.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $54.5M | +13.1% | -52.3% |
| Accounts Receivable | $14.3M | -22.4% | -6.1% |
| Inventory | $16.1M | -10.8% | -8.7% |
| Current Assets | $122.2M | -27.0% | -53.7% |
| Total Assets | $203.5M | -23.3% | -49.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$145.9M | — | — |
| Capital Expenditures | $766K | — | — |
| Investing Cash Flow | $81.7M | — | — |
| Financing Cash Flow | $36.6M | — | — |
| Free Cash Flow | -$146.7M | — | — |
| $62.7M |
| -9.4% |
| -28.5% |
| Long-term Debt | $429.2M | -0.1% | — |
| Total Liabilities | $505.1M | -1.6% | -23.6% |
| Stockholders' Equity | -$304.9M | -12.0% | -18.2% |